02655nam 2200433 450 991074132410332120240215214243.01-83768-033-710.5772/intechopen.100951(CKB)5680000000346531(NjHacI)995680000000346531(EXLCZ)99568000000034653120240215d2023 uy 0engur|||||||||||txtrdacontentcrdamediacrrdacarrierPossibilities and Limitations in Current Translational Stem Cell Research /Diana Kitala, Andrei Surguchov, editorsLondon :IntechOpen,2023.1 online resource (364 pages)Biochemistry ;441-83768-032-9 1. Membrane-to-Nucleus Signaling in Human Blood Progenitor Cells Reveals an Efficient GM-Free Reprogramming to Pluripotency -- 2. Activation and Metabolic Shifting: An Essential Process to Mesenchymal Stromal Cells Function -- 3. Stem Cell-Derived Exosomes as New Horizon for Cell-Free Therapeutic Development: Current Status and Prospects -- 4. Evaluation and Characterization of Human Bone Marrow Mesenchymal Stromal Cells Cryopreserved in Animal Component-Free, Chemically Defined, Serum-Free Conditions -- 5. Nanotechnology-Based Stem Cell Therapy: Current Status and Perspectives.Although the concept of using advanced therapy products such as stem cells seems to be a key strategy in the treatment of various diseases, much information in this area remains unknown. Stem cell products are highly complex, much more complex than chemical-based drugs. More and more often there are data indicating the risk of using stem cells. These risks are determined by various factors that are related to quality, biological activity, and the use itself, and thus administration. Therefore, it is very important to constantly systematize knowledge in this area. This book was created to present both the perspective of basic research, including the manipulation and changes in the properties of cells, and the changes and novelties in therapies themselves.Biochemistry ;44.Cellular biology (cytology)Stem cellsResearchCellular biology (cytology)Stem cellsResearch.574.876Kitala DianaSurguchov AndreiNjHacINjHaclBOOK9910741324103321Possibilities and Limitations in Current Translational Stem Cell Research3555648UNINA